Humanities and Social Sciences, Год журнала: 2025, Номер 13(3), С. 219 - 227
Опубликована: Май 22, 2025
This article traces the evolution of a real-world evidence (RWE) platform for cannabis research, from its pilot phase as "Real-World Data on Therapeutic Response to Cannabis Products in Medical and Veterinary Practice" project Brazil proposed enhancement through strategic China-Brazil partnership. The initial demonstrated feasibility collecting valuable data therapeutic outcomes, product characteristics, patient experiences. Building this foundation, collaboration leverages China's technological expertise Brazil's research capacity, specifically Chinese artificial intelligence (AI), big analytics, digital health technology infrastructure, combined with Brazilian capacity conducting clinical studies, access diverse populations, knowledge biodiversity, scale platform, incorporate advanced harmonize regulatory frameworks, navigating distinct landscapes both countries, including current restrictions China cannabinoid use, while acknowledging role major producer industrial hemp growing investment biotechnological research. integrated approach aims accelerate development evidence-based therapies policies, fostering innovation responsible growth within industry, also addressing planetary concerns. align scientific advancement ethical sustainability considerations, reflecting vision.
Язык: Английский